Format

Send to

Choose Destination
Ann Oncol. 2016 Sep;27(suppl 5):v119-v133.

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.

Author information

1
Medical Oncology, Santa Maria Hospital, Terni, Italy.
2
School of Nursing, The Hong Kong Polytechnic University, Hong Kong, China SAR.
3
Department of Oncology, Odense University Hospital, Odense, Denmark.
4
Clinique de Genolier, Multidisciplinary Oncology Institute, Genolier, Switzerland.
5
Albert Einstein College of Medicine, Jacobi Medical Center, New York.
6
Department of Palliative, Rehabilitation and Integrative Medicine, UT MD Anderson Cancer Center, Houston.
7
The University of Kansas Cancer Center, Westwood, Kansas, USA.
8
Department of Pharmacy and Research Institute, The Hospital for Sick Children, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
9
Division of Hematology-Oncology, Simon Cancer Center, Indiana University, Indianapolis, USA.
10
Department of Radiation Oncology, Vivantes Clinics, Neukoelln, Berlin, Germany.
11
Lahey Health Cancer Institute, Burlington, USA.
12
Department of Hematology/Oncology, Martin-Luther-University Halle-Wittemberg, Halle, Germany.
13
Sansom Institute for Health Research, University of South Australia, Adelaide, Australia.
14
Medical Oncology Centre of Rosebank, Johannesburg, South Africa.
15
Department of Surgery, University of Rochester Medical Center, Rochester, USA.
16
Academic Department of Palliative Medicine, Our Lady's Hospice and Care Services, Dublin, Ireland.
17
Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Canada.
18
Department of Paediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands.
PMID:
27664248
DOI:
10.1093/annonc/mdw270

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center